1. 73-96 of 347 « 1 2 3 4 5 6 7 ... 13 14 15 »
    1. Tetraphase Pharmaceuticals Adds Nancy J. Wysenski to Board of Directors

      Tetraphase Pharmaceuticals Adds Nancy J. Wysenski to Board of Directors

      WATERTOWN, Mass.--(BUSINESS WIRE)--March 13, 2014-- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today announced the addition of Nancy J. Wysenski to the company's Board of Directors. Ms. Wysenski has more than 35 years' experience in the life science industry, the majority of which have been spent in commercial leadership roles.

      Read Full Article
    2. CSG's Paul Nguyen Named to the ISA Board of Directors

      CSG's Paul Nguyen Named to the ISA Board of Directors

      ENGLEWOOD, Colo.--(BUSINESS WIRE)--March 11, 2014--CSG International, Inc. (NASDAQ: CSGS), a global provider of interactive transaction-driven solutions and services, today announced that Paul Nguyen, president of CSG Invotas global security solutions, has been named to the Internet Security Alliance (ISA) board of directors

      Read Full Article
    3. Sorrento Therapeutics Appoints Mark Durand to its Board of Directors

      Sorrento Therapeutics Appoints Mark Durand to its Board of Directors

      SAN DIEGO, March 11, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and associated pain, today announced the addition of industry veteran Mark W. Durand to its Board of Directors.

      Read Full Article
    4. Hill-Rom Elects William G. Dempsey to its Board of Directors

      Hill-Rom Elects William G. Dempsey to its Board of Directors

      BATESVILLE, Ind., March 10, 2014 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that William G. Dempsey has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. 

      Read Full Article
    5. Stan Lybarger Elected to Cypress Energy Partners, L.P. Board of Directors

      Stan Lybarger Elected to Cypress Energy Partners, L.P. Board of Directors

      TULSA, Okla.--(BUSINESS WIRE)--March 05, 2014-- The Board of Directors of the general partner of Cypress Energy Partners, L.P. (NYSE:CELP), a Delaware limited partnership ("Cypress"), has elected Stanley A. Lybarger to its board, effective March 5, 2014. With Lybarger's election, the board of directors now has 6 members, 3 of whom are independent. Lybarger will also become the Chairman of the audit committee.

      Read Full Article
    6. Ignite Restaurant Group Appoints Robert S. Merritt to its Board of Directors

      Ignite Restaurant Group Appoints Robert S. Merritt to its Board of Directors

      HOUSTON--(BUSINESS WIRE)--March 05, 2014--Ignite Restaurant Group (NASDAQ:IRG) today announced that Robert S. Merritt has been appointed as an independent member of its Board of Directors, effective March 4, 2014. Mr. Merritt will replace Zane Leshner, who resigned from the Board of Directors effective February 27, 2014.

       

      Read Full Article
    7. Jarden Corporation Appoints Ros L'esperance to its Board of Directors

      Jarden Corporation Appoints Ros L'esperance to its Board of Directors

      MIAMI, March 6, 2014 /PRNewswire/ -- Jarden Corporation (NYSE:JAH) today announced the appointment of Ros L'Esperance to its Board of Directors effective immediately. With the appointment, the Company's Board of Directors consists of ten members, including seven independent directors.

      Read Full Article
    8. MacroGenics Appoints Matthew Fust to Its Board of Directors

      MacroGenics Appoints Matthew Fust to Its Board of Directors

      ROCKVILLE, Md., March 6, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX) today announced that its Board of Directors is increasing its size from seven to eight members and that Matthew Fust has been appointed to fill the vacancy. Mr. Fust joins the Board and becomes Chairman of its Audit Committee, effective immediately. Mr. Fust will serve as a Class II Director, with Class II having a term expiring at the annual meeting of stockholders to be held in 2015.

       

      Read Full Article
    9. McKesson Board of Directors Elects N. Anthony Coles as New Independent Director

      McKesson Board of Directors Elects N. Anthony Coles as New Independent Director

      SAN FRANCISCO--(BUSINESS WIRE)--March 05, 2014--As a next step in a series of corporate governance modifications, McKesson Corporation (NYSE: MCK) today announced that its Board of Directors has elected N. Anthony Coles, M.D., as a new independent director, effective April 29, 2014. In connection with Dr. Coles' election, the size of the Board of Directors was increased from nine to ten members, nine of whom are independent.

       

      Read Full Article
    10. Richard Nottenburg Elected to Violin Memory Board of Directors

      Richard Nottenburg Elected to Violin Memory Board of Directors

      SANTA CLARA, Calif.--(BUSINESS WIRE)--March 03, 2014--Violin Memory(R), Inc., (NYSE:VMEM), a leader in persistent memory-based storage solutions, today announced that Dr. Richard N. Nottenburg has been elected to its Board of Directors, effective February 28, 2014. Dr. Nottenburg is a business consultant and private investor working with early-stage and established technology companies in the semiconductor, software and wireless communications industries.

       

      Read Full Article
    11. Synthetic Biologics' Board of Directors Accepts Resignation of Long-Standing Founder and Board Member

      Synthetic Biologics' Board of Directors Accepts Resignation of Long-Standing Founder and Board Member

      ROCKVILLE, Md., Feb. 26, 2014 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases, announced today that Founder, Board member and subsidiary CEO and President, Steve H. Kanzer, has resigned from the Company, effective immediately, to return his focus to his venture capital and investment banking firms on a full-time basis.

      Read Full Article
    12. Peggy Vaughan Joins MoneyGram Board of Directors

      Peggy Vaughan Joins MoneyGram Board of Directors

      DALLAS--(BUSINESS WIRE)--February 24, 2014-- MoneyGram International (NASDAQ:MGI), a leading global money transfer and payment services company, today announced that Peggy Vaughan has been appointed to the MoneyGram Board of Directors. This brings the total number of directors to nine, five of whom are independent. Vaughan will serve on the Board's Audit Committee.

      Read Full Article
    13. Extreme Networks Appoints Randi Paikoff Feigin to Board of Directors

      Extreme Networks Appoints Randi Paikoff Feigin to Board of Directors

      SAN JOSE, Calif., Feb. 19, 2014 /PRNewswire/ -- Extreme Networks, Inc. (Nasdaq: EXTR) today announced the appointment of Randi Paikoff Feigin, a seasoned industry veteran and former Juniper Networks executive, to its board of directors, effective Feb. 13, 2014. Mrs. Feigin is a dynamic Silicon Valley leader with a successful track record over the past two decades.

      Read Full Article
    14. CIT Names Sheila A. Stamps to Board of Directors

      CIT Names Sheila A. Stamps to Board of Directors

      CIT Group Inc. (NYSE: CIT) cit.com, a leading provider of financing and advisory services to small businesses and middle market companies, today announced that Sheila A. Stamps has been named to CIT's Board of Directors effective immediately. She will serve as a member of CIT's Risk Management and Regulatory Compliance Committees.

      Read Full Article
    15. Dr. Rodney S. Markin Joins Trovagene's Board of Directors

      Dr. Rodney S. Markin Joins Trovagene's Board of Directors

      SAN DIEGO, Feb. 19, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that Dr. Rodney S. Markin has joined the Company's Board of Directors. Dr. Markin is a hepatic pathologist by training, and is a leading authority in the field of laboratory automation.

      Read Full Article
    16. Richard Mora Joins Enphase Energy Board of Directors

      Richard Mora Joins Enphase Energy Board of Directors

      PETALUMA, Calif., Feb. 18, 2014 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (Nasdaq:ENPH) announces Richard Mora as the newest member of the Board of Directors. Mora is currently the chief operating officer of Landis+Gyr and brings a wealth of corporate strategy expertise, particularly in the smart grid and smart metering arena, to the Board.

      Read Full Article
    17. Navidea Biopharmaceuticals Adds New Member to Board of Directors

      Navidea Biopharmaceuticals Adds New Member to Board of Directors

      Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Perry A. Karsen has been appointed to the Navidea Board of Directors. Mr. Karsen has more than 30 years of experience in the pharmaceutical and biotechnology industries, including key roles at Celgene Corporation. His appointment increases the number of directors on Navidea's Board to seven.

      Read Full Article
    18. Charles Calomiris and Allan Meltzer: How Dodd-Frank Doubles Down on 'Too Big to Fail'

      Charles Calomiris and Allan Meltzer: How Dodd-Frank Doubles Down on 'Too Big to Fail'

      [Registration Required] The Dodd-Frank Act, passed in 2010, mandated hundreds of major regulations to control bank risk-taking, with the aim of preventing a repeat of the taxpayer bailouts of "too big to fail" financial institutions. These regulations are on top of many rules adopted after the 2008 financial crisis to make banks more secure. Yet at a Senate hearing in January, Elizabeth Warren asked a bipartisan panel of four economists (including Allan Meltzer) whether the Dodd-Frank Act would end the problem of too-big-to-fail banks. Every one answered no.

      Read Full Article
    73-96 of 347 « 1 2 3 4 5 6 7 ... 13 14 15 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content